On Monday, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) opened higher 7.07% from the last session, before settling in for the closing price of $1.98. Price fluctuations for MRVI have ranged from $1.66 to $11.56 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 42.54%. Company’s average yearly earnings per share was noted -162.56% at the time writing. With a float of $117.02 million, this company’s outstanding shares have now reached $141.98 million.
Let’s determine the extent of company efficiency that accounts for 570 employees. In terms of profitability, gross margin is 39.14%, operating margin of -90.29%, and the pretax margin is -100.89%.
Maravai LifeSciences Holdings Inc (MRVI) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Maravai LifeSciences Holdings Inc is 18.71%, while institutional ownership is 81.32%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -162.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.94% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
Check out the current performance indicators for Maravai LifeSciences Holdings Inc (MRVI). In the past quarter, the stock posted a quick ratio of 6.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Looking closely at Maravai LifeSciences Holdings Inc (NASDAQ: MRVI), its last 5-days average volume was 1.89 million, which is a drop from its year-to-date volume of 2.92 million. As of the previous 9 days, the stock’s Stochastic %D was 40.28%. Additionally, its Average True Range was 0.15.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 10.01%, which indicates a significant decrease from 65.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.49% in the past 14 days, which was lower than the 84.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2200, while its 200-day Moving Average is $5.6100. However, in the short run, Maravai LifeSciences Holdings Inc’s stock first resistance to watch stands at $2.1600. Second resistance stands at $2.2100. The third major resistance level sits at $2.2800. If the price goes on to break the first support level at $2.0400, it is likely to go to the next support level at $1.9700. Should the price break the second support level, the third support level stands at $1.9200.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
There are currently 254,336K shares outstanding in the company with a market cap of 305.20 million. Presently, the company’s annual sales total 259,190 K according to its annual income of -144,850 K. Last quarter, the company’s sales amounted to 56,410 K and its income totaled -26,150 K.
